Fig. 7From: Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular dockingMolecular Dynamics Simulation. A RMSD Analysis of biochanin A-AKT1. B RMSF Analysis of biochanin A-AKT1. C: Rg of biochanin A-AKT1. D: RMSD Analysis of biochanin A-TNF-α. E RMSF Analysis of biochanin A-TNF-α. F Rg of biochanin A-TNF-αBack to article page